Dr. Tina Bhutani reviews real-world data showing improved patient-reported outcomes and satisfaction with tildrakizumab in moderate-to-severe plaque psoriasis.
Topics Covered:
Dr. Lio discusses his article published in the December 2025 issue of JCAD, titled “PDE4 Inhibitor-Responsive Dermatoses: An Emerging Concept in Dermatology.” Read the full
Dr. Marianna Blyumin-Karasik reviews a new JCAD article proposing a system to identify and classify topical adaptogens in dermatology. Topics Covered: Definition and scope of
Drs. Bunick and Del Rosso discuss an article published in JCAD September 2025, titled “Clindamycin Phosphate 1.2%/Adapalene 0.15%/Benzoyl Peroxide 3.1% to Treat Acne Induced by
Dr. Dasilva discusses his article published in JCAD September 2025, titled “Nemolizumab Demonstrates Marked Efficacy in Challenging Chronic Pruritus: A Real-world Multicenter Case Series.” Read
Dr. Emmy Graber presents pilot study results on a combination acne regimen featuring clindamycin/adapalene/BPO gel plus clascoterone cream in adult patients. Topics Covered: Combination topical
Dr. Naiem T. Issa presents a case series on the real-world application of Tapinarof Cream 1% once daily in patients with seborrheic dermatitis, highlighting its
Dr. Nada Elbuluk presents findings on how outpatient dermatology patients use the internet and social media to acquire dermatology-related information. Topics Covered: Patient behavior in
Alice Gottlieb, MD, PhD, discusses a new article published in the October 2024 issue of JCAD that sought to correlate the time lag between psoriatic
James Del Rosso, DO, Clinical Editor-in-Chief of JCAD, discusses a new review article published in the August 2024 issue of JCAD, titled “Clindamycin: A Comprehensive
